INS and obesity disorder: Increasing 15-keto-PGE2 through either genetic disruption or pharmacological inhibition of its degrading enzyme PTGR2 or direct injection of 15-keto-PGE2 into mice improved insulin sensitivity and prevented diet-induced obesity.